Key facts
- This page summarizes Craig Eagle's Form 4 filing for Guardant Health, Inc. (GH).
- 11 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 05 Jan 2026, 17:58.
Craig Eagle - 01 Jan 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- GH
- Reported as of
- 01 Jan 2026
- Net transaction value
- -$1,176,857
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2026, 17:58:43 UTC
- Prior SEC filing
- 17 Dec 2025
- Next SEC filing
- 17 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John G. Saia, as attorney-in-fact for Craig Eagle
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Craig Eagle filed Form 4 for Guardant Health, Inc. (GH) on 05 Jan 2026.
Change
- Previous filing in this sequence was filed on 17 Dec 2025.
- Current net transaction value: -$1,176,857.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001562135
Primary reporting owner
EAGLE CRAIG
- Relationship
- Chief Medical Officer
- Address
- 3100 HANOVER STREET, PALO ALTO
- Signature
- /s/ John G. Saia, as attorney-in-fact for Craig Eagle
- Signature date
- 05 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,714
- Change %
- +3.8%
- Price
- $0.000000
- Shares after
- 46,721
- Date
- 01 Jan 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +13,714
- Change %
- +29%
- Price
- $0.000000
- Shares after
- 60,435
- Date
- 01 Jan 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,667
- Change %
- +2.8%
- Price
- $0.000000
- Shares after
- 62,102
- Date
- 01 Jan 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +5,688
- Change %
- +9.2%
- Price
- $0.000000
- Shares after
- 67,790
- Date
- 01 Jan 2026
- Ownership
- Direct
GH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,659
- Change %
- +3.9%
- Price
- $0.000000
- Shares after
- 70,449
- Date
- 01 Jan 2026
- Ownership
- Direct
GH
transaction
Common Stock
Tax liability
- Transaction value
- $1,176,857
- Shares
- -11,522
- Change %
- -16%
- Price
- $102.14
- Shares after
- 58,927
- Date
- 01 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,714
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 5,143
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,714
- Exercise price
- $0.000000
- Footnotes
- F2, F3
GH
transaction
Derivative
Performance-Based Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -13,714
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,714
- Exercise price
- $0.000000
- Footnotes
- F3, F4
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,667
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 5,002
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,667
- Exercise price
- $0.000000
- Footnotes
- F3, F5
GH
transaction
Derivative
Performance-Based Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -5,688
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 5,688
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,688
- Exercise price
- $0.000000
- Footnotes
- F3, F6
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -2,659
- Change %
- -12%
- Price
- $0.000000
- Shares after
- 18,615
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,659
- Exercise price
- $0.000000
- Footnotes
- F3, F7
GH
holding
Derivative
Performance-Based Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,714
- Date
- 01 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,714
- Exercise price
- $0.000000
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
Footnote F2
This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
Footnote F3
Not applicable for Restricted Stock Units.
Footnote F4
This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026.
Footnote F5
This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Footnote F6
This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.
Footnote F7
This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.